Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Revance Therapeutics (NQ: RVNC )

27.43 USD +0.63 (+2.35%)
Streaming Delayed Price Updated: 1:34 PM EDT, Apr 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Revance Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a ... 
Tags BPMC pharmaceuticals Market News
From Benzinga
Sum Up The Parts: XPH Could Be Worth $67
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TLIS RVNC VCNX
From Benzinga
Revance Therapeutics' DaxibotulinumtoxinA For Injection Improves Muscle Tone In Mid-Stage Upper Limb Spasticity
Revance Therapeutics Inc(NASDAQ:RVNC) hasreported topline datafromJUNIPER Phase 2 studyevaluating ... 
Tags spasticity Health Care Phase 2
From Benzinga
Recap: Revance Therapeutics Q4 Earnings
Shares of Revance Therapeutics (NASDAQ:RVNC) increasedin after-market trading after the company reported Q4 results. Quarterly ... 
Tags Earnings RVNC Benzinga
From Benzinga
Analysts See 18% Upside For IHE
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Earnings Scheduled For February 22, 2021
Companies Reporting Before The Bell • Cooper Tire & Rubber (NYSE:CTB) is projected to report quarterly earnings at ... 
Tags CDNS HSTM CYRN
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags ICPT ALIM CDNA
From Benzinga
Revance Therapeutics's Earnings Outlook
On Monday, February 22, Revance Therapeutics (NASDAQ:RVNC) will release its latest earnings report. Benzinga's outlook for Revance ... 
Tags RVNC Earnings BZI/EP
From Benzinga
Revance Therapeutics Shows Improved Relative Strength; Still Shy Of Benchmark
Revance Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Stocks Showing Improved Relative Strength: Revance Therapeutics
A Relative Strength Rating upgrade for Revance Therapeutics shows improving technical performance. Will it continue? 
From Investor's Business Daily
Stocks Generating Improved Relative Strength: Revance Therapeutics
Revance Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Revance Therapeutics Shows Improved Relative Price Performance; Still Shy Of Benchmark
Revance Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the Thanksgiving holiday. The week kickstarted with lukewarm news on the... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the ... 
Tags BYSI HCM CRVS
From Benzinga
Attention Biotech Investors: Mark Your Calendar For Dec. PDUFA Dates
The U.S. Food and Drug Administration's approval machinery churned out a lot of disappointments in November. Most of the negative verdicts were tied to difficulties the agency had in inspecting... 
Tags Stocks / Equities Healthcare Pharma/Biotech
From Blogs - TalkMarkets
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
The U.S. Food and Drug Administration'sapproval machinery churned out a lot of disappointments in November. Most of the ... 
Tags UROV ALNY AZN
From Benzinga
The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IBB ZLAB RVNC
From Benzinga
Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
Biotech stocks came under pressure in the week ended Nov. 20, reversing course from the previous week. The sector started the week on a strong note, thanks to positive vaccine data reported by Moderna... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
Biotech stocks came under pressure in the week ended Nov. 20, reversing course from the previous week. The sector started the week on a ... 
Tags Market News BNTX Small Cap
From Benzinga
FYC's Holdings Could Mean 16% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AFMD FDA BIO
From Benzinga
Recap: Revance Therapeutics Q3 Earnings
Shares of Revance Therapeutics (NASDAQ:RVNC) decreased 8.62% in after-market trading after the company reported Q3 results. Quarterly ... 
Tags Benzinga Earnings RVNC
From Benzinga
12 Healthcare Stocks Moving In Monday's After-Market Session
Gainers Trxade Group (NASDAQ:MEDS) shares increased by 13.72% to $4.89 during Monday's after-market session. Trading volume for ... 
Tags LJPC AFMD Health Care
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags ICPT CMPI CYCC
From Benzinga
Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates
The month of October could at best be termed as mixed from the perspective of drug approvals. Avenue Therapeutics Inc's (NASDAQ: ... 
Tags News REGN General
From Benzinga
Stocks With Rising Relative Price Strength: Revance Therapeutics
A Relative Strength Rating upgrade for Revance Therapeutics shows improving technical performance. 
From Investor's Business Daily
10 Biggest Price Target Changes For Thursday
JMP Securities boosted Goldman Sachs Group Inc (NYSE: GS) price target from $280 to $285. Goldman Sachs shares fell 1% to $209.19 in ... 
Tags GS Benzinga NFLX
From Benzinga
Analysts Anticipate FAD Will Reach $94
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Interesting RVNC Put And Call Options For November 20th
Investors in Revance Therapeutics Inc (RVNC) saw new options become available this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account